0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters | Less Is More|

Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study FREE

Laura D. K. Thomas, MSc; Carl-Gustaf Elinder, MD; Hans-Göran Tiselius, MD; Alicja Wolk, DrMedSc; Agneta Åkesson, PhD
[+] Author Affiliations

Author Affiliations: Institute of Environmental Medicine, Division of Nutritional Epidemiology (Ms Thomas and Drs Wolk and Åkesson), and Department of Clinical Science, Intervention, and Technology, CLINTEC, (Drs Elinder and Tiselius), Karolinska Institutet, Stockholm, Sweden.


JAMA Intern Med. 2013;173(5):386-388. doi:10.1001/jamainternmed.2013.2296.
Text Size: A A A
Published online

Urinary oxalate is an important determinant of calcium oxalate kidney stone formation.1 Vitamin C is excreted in urine both in its unmetabolized form and as oxalate; however, there remains considerable uncertainty over the kidney stone risk that may be associated with ascorbic acid supplement use.2

We examined whether ascorbic acid supplements (approximately 1000 mg) were associated with kidney stones in a population-based, prospective cohort of men.

The Cohort of Swedish Men (COSM) has been described elsewhere.3 In brief, 48 850 men, aged 45 to 79 years at baseline, were recruited in 1997 (response rate, 49%). Detailed diet and lifestyle data were collected at baseline using a self-administered questionnaire. Based on validated questions, men reported their use of ascorbic acid (sensitivity = 67% and specificity = 93%)4 and of 20 other supplement types. We excluded those with incorrect national registration numbers, implausible energy intake, prebaseline cancer diagnosis, and missing supplement use data and those diagnosed as having kidney stones prior to baseline, based on registry (n = 1612) and self-reported (n = 5898) data, because these men may have changed their diet or supplement use based on medical advice. We also excluded users of supplements other than ascorbic acid as this may be a significant source of confounding (n = 12 873). For comparison, we repeated the analysis for multivitamin (only) users.

First incident cases of kidney stones (International Statistical Classification of Diseases, 10th Revision code N20) were ascertained from January 1, 1998, to December 31, 2009, using registry data.

We estimated hazard ratios (hereafter, relative risks [RRs]) with Cox proportional hazards regression models using attained age as the timescale. Follow-up was censored at date of kidney stone diagnosis, death, or end of follow-up, whichever occurred first. The Schoenfeld residual test indicated no violation of the proportional hazard assumption.

Dose-response was assessed using the frequency-of-use data, which were available for 91.5% of ascorbic acid users. The linear trend across categories was tested using the median tablet usage within each group as a continuous variable.

Ethical approval was granted by the regional ethical review board in Stockholm, Sweden, and return of the completed questionnaire was considered to imply informed consent.

During 11 years of follow-up we ascertained 436 first incident cases of kidney stones. Ascorbic acid use was associated with a statistically significant 2-fold increased risk (Table). In contrast, multivitamin use was not associated with kidney stone risk (RR, 0.86 [95% CI, 0.62-1.19]).

Table Graphic Jump LocationTable. Characteristics of Study Population and Risk of Kidney Stones in Relation to Use of Ascorbic Acid Only in 23355 Swedish Men

Users of only ascorbic acid taking fewer than 7 (median) and 7 or more tablets per week showed increased risks of RR, 1.66 (95% CI, 0.99-2.79) and RR, 2.23 (95% CI, 1.28-3.88), respectively, compared with supplement nonusers in the full multivariate-adjusted model (P value for trend = .001).

The strengths of this study include the large population-based prospective cohort design, validated exposure data, and virtually complete follow-up of the study population through linkage to high-quality registers. Furthermore, analysis of kidney stone material collected from 3176 men, treated with extracorporeal shockwave lithotripsy in Stockholm County, found calcium oxalate to be the dominant component in 92.6% (H.-G.T., unpublished data). It could thus be assumed that at least 90% of the kidney stones in our study population were composed primarily of calcium oxalate.5

Our results may not be generalizable to women, who typically have a much lower kidney stone risk. Because the risk associated with ascorbic acid may depend both on the dose and on the combination of nutrients with which the ascorbic acid is ingested, our findings should not be translated to dietary vitamin C. Data on the brand of supplement used were not available, and we were not, therefore, able to fully characterize the dose taken. However, previous studies have demonstrated that ascorbic acid preparations available on the Swedish market typically contain 1000 mg of ascorbic acid per tablet.6 Supplement users may be more health conscious and therefore more likely to seek medical help; however, given the severe pain associated with kidney stones, this is unlikely to explain our findings. It is also not supported by our null results for multivitamin use. We cannot rule out the possibility of residual confounding.

The rate difference was 147 of 100 000 for first incident cases; however, the recurrent nature of kidney stones implies that the absolute risk increase, for this modifiable risk factor, is potentially higher. Our findings need to be confirmed by other studies but may have important implications for the clinical advice given to kidney stone formers. Currently there are no well-documented benefits of high-dose ascorbic acid supplement use,7 and, therefore, it seems prudent to advise that high-dose preparations be avoided, particularly by those with a history of kidney stones.

In conclusion, our results indicate that high-dose ascorbic acid supplements—one of the most commonly used vitamin preparations—are associated with a dose-dependent 2-fold increased risk of kidney stone formation among men.

Correspondence: Dr Åkesson, Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, PO Box 210, 171 77 Stockholm, Sweden (Agneta.Akesson@ki.se).

Published Online: February 4, 2013. doi:10.1001/jamainternmed.2013.2296

Author Contributions: Dr Thomas and Åkesson had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Thomas, Wolk, and Åkesson. Acquisition of data: Wolk. Analysis and interpretation of data: Thomas, Elinder, Tiselius, Wolk, and Åkesson. Drafting of the manuscript: Thomas and Åkesson. Critical revision of the manuscript for important intellectual content: Thomas, Elinder, Tiselius, Wolk, and Åkesson. Statistical analysis: Thomas. Obtained funding: Wolk and Åkesson. Administrative, technical, and material support: Tiselius and Wolk. Study supervision: Elinder and Åkesson.

Conflict of Interest Disclosures: None reported.

Funding/Support: The research was funded by the Swedish Research Council/Research Infrastructures (grant No. 2008-5947) and Karolinska Institutet KID funding (PhD funding awarded to Ms Thomas).

Role of the Sponsors: The funders had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.

Previous Presentation: This study was presented as a conference poster, “Vitamin C Supplementation and Kidney Stone Incidence Among Men: A Population-Based Prospective Cohort Study,” at the International Conference on Diet and Activity Methods, Food and Organisation; May 15, 2012; Rome, Italy.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.  Kidney Int. 2001;59(6):2290-2298
PubMed
Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.  J Am Soc Nephrol. 2004;15(12):3225-3232
PubMed   |  Link to Article
Messerer M, Håkansson N, Wolk A, Akesson A. Dietary supplement use and mortality in a cohort of Swedish men.  Br J Nutr. 2008;99(3):626-631
PubMed   |  Link to Article
Messerer M, Wolk A. Sensitivity and specificity of self-reported use of dietary supplements.  Eur J Clin Nutr. 2004;58(12):1669-1671
PubMed   |  Link to Article
Tiselius H. Solution chemistry of supersaturation. In: Coe FLFM, Pak CYC, Parks JH, Preminger GM, eds. Kidney Stones, Medical and Surgical Management. Philadelphia, PA: Lippincott-Raven Publishers; 1996:33-64
Messerer M, Johansson SE, Wolk A. The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men.  J Nutr. 2004;134(7):1800-1805
PubMed
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.  Cochrane Database Syst Rev. 2012;3:CD007176
PubMed

Figures

Tables

Table Graphic Jump LocationTable. Characteristics of Study Population and Risk of Kidney Stones in Relation to Use of Ascorbic Acid Only in 23355 Swedish Men

References

Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.  Kidney Int. 2001;59(6):2290-2298
PubMed
Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.  J Am Soc Nephrol. 2004;15(12):3225-3232
PubMed   |  Link to Article
Messerer M, Håkansson N, Wolk A, Akesson A. Dietary supplement use and mortality in a cohort of Swedish men.  Br J Nutr. 2008;99(3):626-631
PubMed   |  Link to Article
Messerer M, Wolk A. Sensitivity and specificity of self-reported use of dietary supplements.  Eur J Clin Nutr. 2004;58(12):1669-1671
PubMed   |  Link to Article
Tiselius H. Solution chemistry of supersaturation. In: Coe FLFM, Pak CYC, Parks JH, Preminger GM, eds. Kidney Stones, Medical and Surgical Management. Philadelphia, PA: Lippincott-Raven Publishers; 1996:33-64
Messerer M, Johansson SE, Wolk A. The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men.  J Nutr. 2004;134(7):1800-1805
PubMed
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.  Cochrane Database Syst Rev. 2012;3:CD007176
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 10

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles